3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
3
Urinary Bladder Neoplasms
1
Tobacco Use Disorder
1
Sunburn
1
Stress, Psychological
1
Stress Disorders, Post-Traumatic
1
Smoking Cessation
1
Prostatic Hyperplasia
1
Motor Activity
1
Melanoma
1
Head and Neck Neoplasms
1
Depression
1
Anxiety Disorders
1
Alzheimer Disease
1
Acquired Immunodeficiency Syndrome
1
Interventions
Zidovudine
3
Tobacco Use Cessation Devices
2
Surveys and Questionnaires
2
Methotrexate
2
Leucovorin
2
Electrocoagulation
2
Dexamethasone
2
Watchful Waiting
1
Vincristine
1
Trichloroacetic Acid
1
Transurethral Resection of Prostate
1
Tomography, X-Ray Computed
1
Therapeutics
1
Self Care
1
Rapid Diagnostic Tests
1
Occult Blood
1
Observation
1
Mammography
1
Inosine Pranobex
1
Fluorouracil
1
Enzyme-Linked Immunosorbent Assay
1
Doxorubicin
1
Cytarabine
1
Cyclophosphamide
1
Bleomycin
1
Biopsy
1
Benzethonium
1
Amyloid
1
Allopurinol
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Acquired Immunodeficiency Syndrome
×
Amyloid
×
Clear all
NCT06883097
2025-12-17
QMH
Wake Forest University Health Sciences
Phase NA
Recruiting
314 enrolled